Related Topics News -

     
 Detail   |   Print 
     
《大行》花旗:市場對可能限制生物製藥技術出口政策過度反應 提供買入良機
2026-06-05T  
國家發改委:推動科技自立自強 深入整治「內捲式」競爭
2026-05-20T  
恆瑞醫藥RSS0393乳膠獲批臨床
2026-05-15T  
恆瑞醫藥SHR-3079注射液獲批臨床
2026-05-14T  
《大行》花旗降恆指今年目標至29,600點 騰訊友邦等為H股首選
2026-05-14T  
《大行》大摩:恆瑞醫藥與BMS締152億美元戰略合作 加速全球化進程
2026-05-13T  
恆瑞醫藥午後抽高逾13% 與百時美施貴寶締全球戰略合作及許可協議 可獲9.5億美元相關付款
2026-05-12T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.